Area of research
Internal Medicine · Cardiology and Cardiovascular Medicine
Research interest
Research interests include Venous Thromboembolism Diagnosis and Management, Atrial Fibrillation Management and Outcomes, Blood Coagulation and Thrombosis Mechanisms, and Diagnosis and Treatment of Venous Diseases.
Risk of Recurrent Venous Thromboembolism in Patients with Cancer: An Individual Patient Data Meta-analysis and Development of a Prediction Model
Recurrent venous thromboembolism and bleeding with extended anticoagulation: the VTE-PREDICT risk score
Treatment of Cancer-Associated Thrombosis: Recent Advances, Unmet Needs, and Future Direction
Abelacimab for Prevention of Venous Thromboembolism
Milvexian for the Prevention of Venous Thromboembolism
Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism
Long‐term risk of recurrent venous thromboembolism among patients receiving extended oral anticoagulant therapy for first unprovoked venous thromboembolism: A systematic review and meta‐analysis
Association Between Asymptomatic Proximal Deep Vein Thrombosis and Mortality in Acutely Ill Medical Patients
Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty
Post-Discharge Prophylaxis With Rivaroxaban Reduces Fatal and Major Thromboembolic Events in Medically Ill Patients
Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer: Results from the Hokusai VTE Cancer study
Clinical implications of incidental venous thromboembolism in cancer patients
Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness
Clinical Impact of Bleeding in Cancer-Associated Venous Thromboembolism: Results from the Hokusai VTE Cancer Study
The Non-Vitamin K Antagonist Oral Anticoagulants in Heart Disease: Section V—Special Situations
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
Global public awareness about atrial fibrillation
Extended duration of anticoagulation with edoxaban in patients with venous thromboembolism: a post-hoc analysis of the Hokusai-VTE study
Recurrent venous thromboembolism in patients with pulmonary embolism and right ventricular dysfunction: a post-hoc analysis of the Hokusai-VTE study
Long-term Anticoagulation With Rivaroxaban for Preventing Recurrent VTE
The economic burden of incident venous thromboembolism in the United States: A review of estimated attributable healthcare costs
Oral apixaban for the treatment of venous thromboembolism in cancer patients: results from the AMPLIFY trial
Global public awareness of venous thromboembolism
Edoxaban for treatment of venous thromboembolism in patients with cancer
Factor XI Antisense Oligonucleotide for Prevention of Venous Thrombosis
Thrombosis: a major contributor to the global disease burden
Thrombosis: A major contributor to global disease burden
Thrombosis: A Major Contributor to Global Disease Burden
Clinical features of paediatric pulmonary hypertension: a registry study